Actinium Pharmaceuticals Current Deferred Revenue (Quarterly) Analysis

Actinium Pharmaceuticals, Inc. (ATNM)

1.38 -0.04 (-2.82%) USD | NYAM | Dec 30, 16:00

1.38 0.00 (0.00%) After-Hours: 20:00

View Current Deferred Revenue (Quarterly) for ATNM.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Current Deferred Revenue (Quarterly) Benchmarks

Start Trial

Arcus Biosciences, Inc.	Upgrade
Apyx Medical Corp.	Upgrade
AbbVie, Inc.	--
Karyopharm Therapeutics, Inc.	--
NovaBay Pharmaceuticals, Inc.	--